This monthly update highlights key regulatory developments, enforcement trends, and compliance issues affecting health-care providers across the continuum – from solo practices to hospitals and large physician groups. Each section includes practical action items to help you assess risk and prepare for upcoming obligations.
Regulatory Developments
Continued Enforcement Focus on Data Security and Billing Integrity
Federal regulators continue to prioritize HIPAA Security Rule compliance under 45 C.F.R. Part 164, Subpart C, particularly the required risk analysis under 45 C.F.R. § 164.308(a)(1)(ii)(A). Agencies also remain focused on timely reporting and repayment of identified overpayments under the 60-Day Rule, 42 U.S.C. § 1320a-7k(d) and 42 C.F.R. § 401.305. In addition, referral relationships and marketing arrangements continue to receive scrutiny under the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b). Recent enforcement activity from HHS’s Office for Civil Rights and the Department of Justice underscores a consistent message: regulators expect proactive compliance infrastructure, documented oversight, and timely corrective action.
Action Items:
- Confirm your HIPAA Security Risk Analysis is current and reflects ransomware and third-party access risks.
- Conduct a tabletop exercise to test breach response procedures.
- Audit internal billing practices for medical necessity documentation and modifier usage.
- Review referral and marketing relationships for written documentation and regulatory compliance.
Contracting Focus
Fair Market Value and Commercial Reasonableness
Compensation arrangements remain one of the most common enforcement triggers under the Stark Law, 42 U.S.C. § 1395nn and its implementing regulations at 42 C.F.R. §§ 411.351 and 411.357, as well as under the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), and its regulatory safe harbors at 42 C.F.R. § 1001.952. Regulators are evaluating not only whether contracts exist, but whether they are commercially reasonable, supported by fair market value, and consistent with actual operational practices. Agreements that appear compliant on paper may still present risk if services are not performed as documented or if compensation methodology raises referral concerns.
Action Items:
- Review expiring physician, medical director, and management agreements.
- Confirm services described in agreements are actually performed and documented.
- Update fair market value support when compensation changes.
- Ensure compensation formulas do not take into account the volume or value of referrals where prohibited.
Compliance Focus
Board and Leadership Oversight Expectations
Both the Department of Justice and the Office of Inspector General have emphasized active
governance oversight in compliance programs, including in the DOJ’s Evaluation of Corporate Compliance Programs guidance and OIG’s updated General Compliance Program Guidance. A written compliance plan alone is no longer sufficient. Regulators increasingly expect demonstrable leadership engagement, meaningful reporting structures, and documented oversight at the executive and board levels. The absence of documentation often becomes as problematic as the absence of compliance activity itself.
Action Items:
- Ensure compliance reporting occurs regularly at the executive or board level.
- Document leadership discussions regarding compliance risks.
- Confirm anonymous reporting mechanisms are accessible and functional.
- Update annual compliance training to reflect current enforcement priorities.
Litigation & Risk Management Trends
Overpayments, False Claims Exposure, and Employment Claims
Failure to timely return identified overpayments can create exposure under the False Claims Act, 31 U.S.C. §§ 3729–3733. Courts have interpreted “identified” broadly once a provider is put on notice of a potential overpayment, placing increased importance on prompt internal investigation and documentation. Healthcare employers also continue to face retaliation claims under 31 U.S.C. § 3730(h), wage-and-hour disputes under the Fair Labor Standards Act, 29 U.S.C. § 201 et seq., and restrictive-covenant challenges, depending on evolving state-law standards. Strong internal documentation and consistent employment practices significantly reduce litigation risk.
Action Items:
- Establish a written overpayment investigation protocol.
- Document steps taken once a billing issue is discovered.
- Audit wage classification for exempt and non-exempt employees.
- Review restrictive covenants for enforceability under current law.
FAQ of the Month
“If we identify a potential overpayment but are still investigating, when does the 60-day clock start?”
Under 42 U.S.C. § 1320a-7k(d) and 42 C.F.R. § 401.305, the repayment obligation is triggered
once an overpayment is “identified.” Courts have held that identification occurs when a provider has actual knowledge of the overpayment or acts in reckless disregard or deliberate ignorance. The regulation defines “identified” as when a provider has determined, or should have determined through reasonable diligence, that an overpayment was received. Prompt investigation, written documentation of findings, and timely repayment when required are critical to mitigating False Claims Act exposure.
Upcoming Deadlines & Reminders
- Monthly OIG Exclusion Screening: Conduct monthly exclusion screening as recommended by OIG guidance using the List of Excluded Individuals and Entities (LEIE). Screening should be completed before the end of each month, with documentation retained.
- Medicare Revalidation (Rolling Deadlines): CMS continues to issue revalidation notices on a rolling basis. Providers should monitor for revalidation letters and calendar submission deadlines immediately upon notice. Revalidation typically must be completed within 60 days of CMS notification to avoid deactivation.
- HIPAA Security Risk Analysis Review: While HIPAA does not impose a fixed annual deadline, organizations that conduct risk analyses on a calendar-year cycle should schedule completion during Q1 2026 to maintain consistency with 45 C.F.R. § 164.308(a)(1)(ii)(A).
- Overpayment Monitoring and Repayment Protocols: Ensure internal processes are in place to identify, investigate, and timely return overpayments in accordance with 42 U.S.C. § 1320a-7k(d) and 42 C.F.R. § 401.305.
- Corporate Transparency Act (If Applicable): Entities subject to the Corporate Transparency Act should confirm applicable Beneficial Ownership Information reporting obligations under 31 U.S.C. § 5336 and current FinCEN guidance. Enforcement timelines have been subject to ongoing federal litigation, and reporting obligations should be verified prior to filing.
- Annual Compensation Review Preparation: Organizations anticipating mid-year compensation adjustments should begin Stark Law and fair market value review processes early in the year to allow adequate documentation prior to implementation.
Disclaimer: The information provided here is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by this communication. Parties should consult with their own qualified attorney for advice regarding their specific legal situation.
For questions or assistance, contact Paul A. Drey or Emily E. Reiners of the Brick Gentry P.C. Healthcare & Regulatory Team.


